Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203813 · ClinicalTrials.gov registry record · Phase 3
A Risk Based Approach to Improving Chronic Kidney Disease Management
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 10,000
- Enrollment target
NCT01203813: Completed Phase 3 study, sponsored by Brigham and Women's Hospital.
NCT01203813 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 10,000 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1197% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01203813, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10,000 participants
- Enrollment target
Study Summary
Aim 1: To assess whether quality of care for stage 3 chronic kidney disease can be substantially improved over 18 months by: * Point of care electronic alerts to primary care physicians recommending risk-appropriate care, and * Quarterly mailings to patients providing self management support materials, including tailored recommendations based on personalized data from an electronic disease registry Aim 2: To assess the relationship between utilization of the intervention components and primary care physician attitudes towards both chronic kidney disease management and electronic reminder systems.
Primary Outcome
Patients with high risk chronic kidney disease (eGFR 30 to 45; or eGFR 45 to 60 with concurrent diabetes or proteinuria) should receive a nephrology office evaluation within the prior 12 months
Interventions
- OTHER Electronic Decision Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
What the finished NCT01203813 record still lists
NCT01203813 is an interventional study that assigns participants to a tested intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1197% higher).
The record links to 0 conditions, and to 1 intervention - of which Electronic Decision Support is the first listed.
NCT01203813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01203813 about?
NCT01203813 is a clinical study titled "A Risk Based Approach to Improving Chronic Kidney Disease Management". Aim 1: To assess whether quality of care for stage 3 chronic kidney disease can be substantially improved over 18 months by: * Point of care electronic alerts to primary care physicians recommending risk-appropriate care, and * Quarterly mailings to patients providing self management support materi...
What is the current status of trial NCT01203813?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10,000 participants. The study started on 2011-05. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01203813?
The interventions under investigation include: Electronic Decision Support (OTHER).
Who is sponsoring clinical trial NCT01203813?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01203813's enrollment target sits among peer trials
10,000 27th of 2000 higher than 1,972 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia